TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 44 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 637,110 | $3,574,187,000 | 0.71% |
Novo Holdings A/S | 470,946 | $2,642,000 | 0.29% |
Perceptive Advisors | 485,338 | $2,723,000 | 0.24% |
SABBY MANAGEMENT, LLC | 812,200 | $4,556,000 | 0.23% |
FNY Managed Accounts LLC | 6,438 | $36,117,000 | 0.06% |
NJ State Employees Deferred Compensation Plan | 35,000 | $271,000 | 0.06% |
Alyeska Investment Group, L.P. | 315,757 | $1,771,000 | 0.02% |
ROPES WEALTH ADVISORS LLC | 6,000 | $34,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $337,000 | 0.01% |
BlackRock Fund Advisors | 530,538 | $2,976,000 | 0.00% |